Top 10 Peripheral Vascular Device Companies Advancing Vascular Care Innovation

Traditionally, the treatment of peripheral arterial disease started with open surgical bypass and has evolved through percutaneous transluminal angioplasty to present catheter-based therapies. This is driven by iterative device innovation and ongoing regulatory engagement. Various industrial leaders and regulators have shaped the device classification and premarket expectations to enhance performance and safety.

Present therapy has embraced drug-coated balloons, atherectomy systems, drug-eluting stents as well as covered stent grafts, aiming to restore perfusion with around less trauma and less recovery. Clinical investigators and manufacturers are also refining antiproliferative coatings, complex lesion morphology and novel scaffold materials to address the complex lesion morphology.

Additionally, recent studies and company sponsored programs continue to probe long term patency and effective outcomes while collaborating with researchers, resulting in next generation Bioresorbable scaffolds. Moreover, regulatory agencies have also published the guidelines to encourage robust clinical evaluation and streamline review pathways for such technologies.

Fortune Business Insights reported that the peripheral vascular devices industry is observing a CAGR of 5.5% over the forecast period. The market is expected to reach USD 12.62 billion in 2026 and attain USD 19.42 billion by 2034.

List of Top 10 Peripheral Vascular Device Companies Reported by Fortune Business Insights

1. Abbott

Abbott is a significant company that offers a comprehensive portfolio of peripheral vascular devices that are specially designed to treat Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI). This also focuses on minimally invasive solutions for vessel treatment, preparation and closure. Some of its key products include THE Esprit BTK Bioresorbable scaffold, Supera stent, Armanda balloons as well as mechanical thrombectomy systems. In August 2025, the company received CE approval for its dissolving stents for peripheral vascular treatment.

2. Medtronic

Medtronic is one of the top 10 peripheral vascular device companies that designs these products for minimally invasive treatment of venous and arterial diseases. It focuses on restoring blood flow and improving patient outcomes. The company is headquartered in Ireland and offers numerous products to end-users. Some of these are Complete SE vascular stent, Abre venous self-expanding stents, IN. PACT Admiral drug-coated balloon, and SpiderFX embolic protection device.

3. Boston Scientific Corporation

Boston Scientific Corporation, headquartered in the U.S., is known for its peripheral vascular devices that are specially designed to treat Peripheral Artery Disease (PAD) and venous conditions outside the heart. The company uses new technologies that focus on opening blood vessels, managing complex vascular lesions, and removing clots. Some of its key products include Jetstream Atherectomy Systems, Eluvia Drug-Eluting Vascular Stent System, AngioJet Thrombectomy Systems, and Ranger Drug-Coated Balloons.

4. Terumo Corporation

Through its Terumo Interventional Systems (TIS) division, Terumo Corporation provides an exclusive portfolio of advanced devices for diagnosing PAD and interventional oncology. The company is headquartered in Japan. The company’s devices are specially designed to reduce the patient burden by emphasizing on advanced technology, particularly with the use of radial arteries for peripheral procedures. These products are used for treating vessel disease of lower limbs and heart.

5. BD

BD (Becton, Dickinson and Company) is known for its peripheral vascular devices that focus on diagnosis, access and treatment of PAD and CLI. The company is headquartered in the U.S. Some of its solutions include Lifestent Vascular Stents, BD Nexiva Closed IV Catheter System, and other specialized balloons such as UltraScore that aim at enhancing patient outcomes and decreasing vascular complications.

6. Cook Medical

Cook Medical is another portfolio designed for treatment of different diseases. These products focus on access, target and treatment strategies to improve the patient outcomes while decreasing the need for open surgery. The company is headquartered in the U.S. and adopts different innovation technologies approved by regulatory bodies and government agencies.

7. Cardinal Health

Cardinal Health is a prominent player in the peripheral vascular device industry that focuses on managing femoral arterial/venous access sites. Some of its key offerings include MYNX CONTROL VCD, MYNXGRIP Vascular Closure Device. These products utilize extravascular sealant technology to decrease time to hemostasis and avoid leaving intravascular components. It also focuses on safety, efficiency and has different clinical applications.

8. Teleflex Incorporated

Teleflex Incorporated is a U.S. headquartered company that specializes in peripheral vascular devices aimed on vascular access, interventional and structural heart needs. This product demand is majorly driven by the company’s acquisition of Vascular Solutions. Some of its key products include MANTA Vascular Closure Devices for a large-bore femoral access and a range of Arrow access catheters.

9. Merit Medical Systems

Merit Medical System’s peripheral vascular devices are designed for interventional radiology and aim on diagnosing, accessing and treating. Its key products improve procedural efficiency, enhances patient recovery and reduces pain. Some of its key products include Prelude Roadster guide sheaths and ClariVein OC infusion catheter.

10. Getinge AB

Headquartered in Sweden, Getinge AB is known for offering peripheral vascular devices and solutions that are marketed under the Maquet brand. This focuses on treating peripheral vascular and aortic diseases. These products highly focus on graft technology and recently have covered stents.

Growing Focus on Patient-Centric and Precise Devices Would Boost Industry Development in the Future

In the future, the growth trajectory of peripheral vascular devices is toward an ecosystem defined by integration, precision, and patient-centric design. Development of these devices is steadily moving toward intelligent systems that combine advanced biomaterials, real-time imaging, and targeted drug delivery. Various emerging platforms are also expected to leverage artificial intelligence for procedural planning and robotics for enhanced control. With clinical evidence expanding and regulatory science growing, the collaboration between manufacturers, research institutions and clinicians would further accelerate safer innovation. Additionally, the leading companies in the industry are also shaping this landscape by refining existing technologies and reimaging how current vascular disease is detected, monitored and treated. This, the upcoming decade promises a shift where technology and biology converge to reform the standards of peripheral vascular intervention.